BMRN - BioMarin Pharmaceutical Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue1,491,2121,313,6461,116,854889,895
Cost of Revenue1,011,592852,539871,525786,814
Gross Profit479,620461,107245,329103,081
Operating Expenses
Research Development696,328696,328696,328696,328
Selling General and Administrative604,353554,336476,593402,271
Non Recurring----
Others----
Total Operating Expenses1,646,2111,437,2041,378,3261,199,852
Operating Income or Loss-154,999-123,558-261,472-309,957
Income from Continuing Operations
Total Other Income/Expenses Net12,29487,683-569,578155,233
Earnings Before Interest and Taxes-154,999-123,558-261,472-309,957
Interest Expense-43,664-42,707-39,499-38,244
Income Before Tax-142,705-35,875-831,050-154,724
Income Tax Expense-65,49481,167-200,84017,075
Minority Interest----
Net Income From Continuing Ops-77,211-117,042-630,210-171,799
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-77,211-117,042-630,210-171,799
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-77,211-117,042-630,210-171,799